e-ISSN 1726-6890
p-ISSN 1735-0328
Citation data
OpenCitations
Works that cite this article, indexed by OpenCitations.
3 resultsUpdated October 21, 2026
1
QbD-guided pharmaceutical development of Pembrolizumab biosimilar candidate PSG-024 propelled to industry meeting primary requirements of comparability to Keytruda®
European Journal of Pharmaceutical Sciences 173 (2022)
Morteza Jaffar-Aghaei; Farzad Khanipour; Amir Maghsoudi; Rahim Sarvestani; Mahdi Mohammadian; Maryam Maleki; Forugh Havasi; Hossein Rahmani; Amir-Hossein Karagah; Mohammad-Reza Kazemali
2
Bioengineering of Antibody Fragments: Challenges and Opportunities
Bioengineering 10(2) (2023)
Sama Pirkalkhoran; Wiktoria Roksana Grabowska; Hamid Heidari Kashkoli; Reihaneh Mirhassani; David Guiliano; Colin Dolphin; Hanieh Khalili